Speaker illustration

Doctor Ryohei Ono

Chiba University Graduate School of Medicine, Chiba (Japan)

Member of:

European Society of Cardiology

Ryohei Ono, MD, graduated from Chiba University Faculty of Medicine in 2016. He completed post-graduate residency programme and has worked as a clinical fellow in cardiology at Chiba University Hospital. He has a Ph.D. degree.

Comparison of calculation algorithms between arithmetic mean of washout rate and total-count-based washout rate in single-photon emission computed tomography

Event: ESC Congress 2023

Topic: Single Photon Emission Computed Tomography (SPECT)

Session: Another look at the myocardium, valve, and appendages…

Thumbnail

Clinical findings of triglyceride deposit cardiomyovasculopathy

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Rare cardiomyopathies

Thumbnail

Hyperperfusion Injury after Percutaneous Transluminal Renal Angioplasty for Renovascular Hypertension as Sequelae of Neuroblastoma.

Event: ESC Congress 2021 - The Digital Experience

Topic: Clinical

Session: Nightmare at the cath lab

Thumbnail

SPECT-guided myocardial perfusion and metabolic fatty acid planar imaging to assess the severity of the pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension

Event: ESC Congress 2021 - The Digital Experience

Topic: Imaging of Heart Failure

Session: Nuclear Imaging, Cross-Modality and Multi-Modality Imaging ePosters

Thumbnail

The correlations between anti-factor Xa activity values and PT/APTT at peak and trough times in patients with venous thromboembolism using high dose of apixaban

Event: ESC Congress 2020

Topic: Venous Disease

Session: What's New in Peripheral Arterial and Venous Diseases

Thumbnail

The distribution of anti-factor Xa activity value, PT and APTT at peak and trough times in patients with direct anti-factor Xa inhibitors

Event: ESC Congress 2020

Topic: Anticoagulants

Session: Pharmacology and Pharmacotherapy ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb